FDA Warns Canadian Drugmaker for Refusing Photography During Inspection

Drug GMP Report
A A
The FDA cited a Montreal drugmaker for refusing to allow an FDA inspector to take photographs during an inspection — and said that alone can lead to a finding that products are adulterated.

To View This Article:

Login

Subscribe To Drug GMP Report